New Findings from Harbin Medical University Cancer Hospital in the Area of Ovarian Cancer Described (MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma)

Source :: OBGYN & Reproduction Week. September 7, 2020, 376
Publication Year :: 2020
Abstract: 2020 SEP 7 (NewsRx) -- By a News Reporter-Staff News Editor at OBGYN & Reproduction Week -- Investigators publish new report on Oncology - Ovarian Cancer. According to news reporting [...]

Subjects :: Elsevier Inc. -- Reports
Research
Reports
Publishing industry
MicroRNA -- Research -- Reports
Publishing industry -- Research -- Reports
Drug resistance -- Research
Stem cells -- Reports -- Research
Antineoplastic agents -- Research
Ovarian cancer -- Research

Tools